| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $30.7M | +9.7% |
| SG&A Expense | $47.5M | -8.0% |
| Operating Income | -$78.2M | +1.8% |
| Pre-tax Income | -$54.3M | -9.1% |
| Income Tax | -$853K | -168.0% |
| Net Income | -$53.4M | -4.7% |
| EPS (Basic) | -$0.17 | +5.6% |
| EPS (Diluted) | -$0.17 | +5.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.7M | -19.7% |
| Inventory | $558K | +45.7% |
| Current Assets | $348.6M | -12.1% |
| Total Assets | $406.8M | -7.6% |
| Current Liabilities | $20.4M | +5.2% |
| Total Liabilities | $47.9M | -2.1% |
| Stockholders' Equity | $358.9M | -8.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.4M | -21.3% |
| Capital Expenditures | $15.8M | +7.6% |
| Investing Cash Flow | $32.7M | +111.1% |
| Financing Cash Flow | $3.3M | -98.9% |
| Free Cash Flow | -$72.2M | -18.0% |